These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 28430297)

  • 61. Current management of left ventricular assist device erosion.
    Bartoli CR; Demarest CT; Khalpey Z; Takayama H; Naka Y
    J Card Surg; 2013 Nov; 28(6):776-82. PubMed ID: 24033369
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Flap coverage for the treatment of exposed left ventricular assist device (LVAD) hardware and intractable LVAD infections.
    Jacoby A; Stranix JT; Cohen O; Louie E; Balsam LB; Levine JP
    J Card Surg; 2017 Nov; 32(11):732-737. PubMed ID: 29098712
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Multidrug-Resistant Organism Infections in Patients with Left Ventricular Assist Devices.
    Donahey EE; Polly DM; Vega JD; Lyon M; Butler J; Nguyen D; Pekarek A; Wittersheim K; Kilgo P; Paciullo CA
    Tex Heart Inst J; 2015 Dec; 42(6):522-7. PubMed ID: 26664303
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Single versus multi-drug antimicrobial surgical infection prophylaxis for left ventricular assist devices: A systematic review and meta-analysis.
    Patel S; Choi JH; Moncho Escrivá E; Rizvi SSA; Maynes EJ; Samuels LE; Luc JGY; Morris RJ; Massey HT; Tchantchaleishvili V; Aburjania N
    Artif Organs; 2019 Jul; 43(7):E124-E138. PubMed ID: 30810232
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Modified HeartMate II driveline externalization technique significantly decreases incidence of infection and improves long-term survival.
    Singh A; Russo MJ; Valeroso TB; Anderson AS; Rich JD; Jeevanandam V; Akhter SA
    ASAIO J; 2014; 60(6):613-6. PubMed ID: 25072552
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pseudomonas aeruginosa left ventricular assist device (LVAD) driveline infection acquired from the bathroom at home.
    Dix LML; de Goeij I; Manintveld OC; Severin JA; Verkaik NJ
    Am J Infect Control; 2022 Dec; 50(12):1392-1394. PubMed ID: 35569615
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Electrical storm in the early phase of HeartMate
    Corre J; Picard F; Garcia R; Zemmoura A; Derval N; Denis A; Romen A; Nubret K; Jais P; Haissaguerre M; Dos Santos P; Barandon L; Sacher F
    Arch Cardiovasc Dis; 2018 May; 111(5):332-339. PubMed ID: 29217463
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical management for complications related to implantable LVAD use.
    Toda K; Sawa Y
    Gen Thorac Cardiovasc Surg; 2015 Jan; 63(1):1-7. PubMed ID: 25370679
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Surgically Corrected Mitral Regurgitation During Left Ventricular Assist Device Implantation Is Associated With Low Recurrence Rate and Improved Midterm Survival.
    Tanaka A; Onsager D; Song T; Cozadd D; Kim G; Sarswat N; Adatya S; Sayer G; Uriel N; Jeevanandam V; Ota T
    Ann Thorac Surg; 2017 Mar; 103(3):725-733. PubMed ID: 27659599
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Midterm outcome of implantable left ventricular assist devices as a bridge to transplantation: Single-center experience in Japan.
    Kimura M; Kinoshita O; Nawata K; Nishimura T; Hatano M; Imamura T; Endo M; Kagami Y; Kubo H; Kashiwa K; Kinugawa K; Kyo S; Komuro I; Ono M
    J Cardiol; 2015 May; 65(5):383-9. PubMed ID: 25034705
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The association of pretransplant HeartMate II left ventricular assist device placement and heart transplantation mortality.
    Donneyong M; Cheng A; Trivedi JR; Schumer E; McCants KC; Birks EJ; Slaughter MS
    ASAIO J; 2014; 60(3):294-9. PubMed ID: 24614355
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Temporary right ventricular support following left ventricle assist device implantation: a comparison of two techniques.
    Noly PE; Kirsch M; Quessard A; Leger P; Pavie A; Amour J; Leprince P
    Interact Cardiovasc Thorac Surg; 2014 Jul; 19(1):49-55. PubMed ID: 24659551
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Obesity and left ventricular assist device driveline exit site infection.
    Raymond AL; Kfoury AG; Bishop CJ; Davis ES; Goebel KM; Stoker S; Selzman CH; Clayson SE; Smith H; Cowley CG; Alharethi R; Budge D; Reid BB
    ASAIO J; 2010; 56(1):57-60. PubMed ID: 20051832
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Left ventricular assist device-related infections: does the time of onset matter?
    Lehnert AL; Hart A; Brouse SD; Charnigo RJ; Branam S; Guglin ME
    J Artif Organs; 2019 Jun; 22(2):98-103. PubMed ID: 30386926
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Outcomes of Heart Transplant After Left Ventricular Assist Device Specific and Related Infection.
    Tong MZ; Smedira NG; Soltesz EG; Starling RC; Koval CE; Porepa L; Moazami N
    Ann Thorac Surg; 2015 Oct; 100(4):1292-7. PubMed ID: 26188972
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Device exchange after primary left ventricular assist device implantation: indications and outcomes.
    Stulak JM; Cowger J; Haft JW; Romano MA; Aaronson KD; Pagani FD
    Ann Thorac Surg; 2013 Apr; 95(4):1262-7; discussion 1267-8. PubMed ID: 23063192
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Usefulness of Speckle Tracking Strain Echocardiography for Assessment of Risk of Ventricular Arrhythmias After Placement of a Left Ventricular Assist Device.
    Akhabue E; Seok Park C; Pinney S; Anyanwu A; Chaudhry F; Narula J; Nair A; Sengupta PP
    Am J Cardiol; 2017 Nov; 120(9):1578-1583. PubMed ID: 28882335
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Extracorporeal membrane oxygenation as perioperative right ventricular support in patients with biventricular failure undergoing left ventricular assist device implantation.
    Scherer M; Sirat AS; Moritz A; Martens S
    Eur J Cardiothorac Surg; 2011 Jun; 39(6):939-44; discussion 944. PubMed ID: 21071240
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Reduce Driveline Trauma Through Stabilization and Exit Site Management: 30 Days Feasibility Results from the Multicenter RESIST Study.
    Stahovich M; Sundareswaran KS; Fox S; Hallinan W; Blood P; Chen L; Pamboukian SV; Chinn R; Farrar DJ; Pagani FD; Blue L
    ASAIO J; 2016; 62(3):240-5. PubMed ID: 27111738
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Variability in fibrosis in tissue samples obtained during diaphragmatic and apical LVAD implantation.
    Segura AM; Radovancevic R; Aguayo A; Frazier OH; Buja LM
    Cardiovasc Pathol; 2014; 23(3):121-5. PubMed ID: 24484611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.